Skip to main content
Clinical Trials/CTRI/2018/12/016813
CTRI/2018/12/016813
Other
N/A

A Multicenter Registry Examining the Clinical Utility of CANscript in Routine Clinical Practice. - PREDiCTS-India Registry

Mitra RxDx India Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: null- Solid cancer
Sponsor
Mitra RxDx India Pvt Ltd
Status
Other
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Mitra RxDx India Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • Patient who has been recommended to undergo
  • CANscript testing, as a part of routine
  • clinical practice, by the treating physician.
  • Patient for whom the CANscript test report
  • (at least 1 reported M\-score) is available
  • Patient willing to provide informed consent
  • for prospective data collection

Exclusion Criteria

  • No specific exclusion criteria can be defined for the registry enrollment.

Outcomes

Primary Outcomes

Not specified

Similar Trials